Reports
Reports
Sale
The Germany bioinformatics market size has been growing at a rapid rate, driven by an exponential growth in data and advancements in technologies accompanied with the rise in machine learning and artificial intelligence. The market size is anticipated to grow at a CAGR of 29% during the forecast period of 2024-2032.
Bioinformatics refer to the science of collecting, storing, analysing, and interpreting biological facts and information, such as DNA, RNA, amino acid sequences and more. Bioinformatics is a combination of several disciplines like mathematics, computer science, medicine and biology which puts forth standards to analyse and interpret data. It is particularly useful in studying DNA sequencing and genomes. common uses of bioinformatics include sequence analysis, genome annotation, prediction of protein structure, and more. Some of the commonly used bioinformatics tools available to researchers and analyst are BLAST, UCGC genome browser, Bioconductor, and more.
Bioinformatics has revolutionized the medical industry in many folds, offering numerous benefits. Further, it has the potential to handle and make sense of vast quantities of data generated through computational and statistical techniques. In recent years, German bioinformatics has witnessed a surge of new trends, shaping the future of the field globally. The emphasis on big data management, driven by the exponential growth of data from genomic sequencing and other technologies, has contributed to the German bioinformatics market growth. The rise of machine learning and artificial intelligence has also transformed how biological data is analyzed and interpreted, adding to the capabilities of bioinformatics.
Based on segments, the market is divided into product and services, applications, and sectors.
Market Breakup by Product and Services
Germany Bioinformatics Market Breakup by Applications
Market Breakup by Sectors
Bioinformatics have brought about a significant transformation in the medical field, providing an array of advantages and promising even more growth. Lately, the bioinformatics industry in Germany has seen several creative innovations that are impacting the discipline's trajectory globally. The emphasis on big data management has been a primary driver of the German bioinformatics market development, spurred by the fast increase in data from genomic sequencing and comparable technologies. Furthermore, the advent of machine learning and artificial intelligence has radically altered the way biological data is handled and analysed, boosting the potential of bioinformatics even further.
The comprehensive EMR report provides an in-depth assessment of the market based on Porter's five forces model, along with giving a SWOT analysis. The report gives a detailed analysis of the following bioinformatics companies in the market, covering their competitive landscape and the latest developments like mergers, acquisitions, investments, and expansion plans.
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Product and Services |
|
Breakup by Applications |
|
Breakup by Sectors |
|
Market Dynamics |
|
Competitive Landscape |
|
Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Germany Bioinformatics Market Overview
3.1 Germany Bioinformatics Market Historical Value (2017-2023)
3.2 Germany Bioinformatics Market Forecast Value (2024-2032)
4 Germany Bioinformatics Market Landscape
4.1 Germany Bioinformatics Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Germany Bioinformatics Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Technology
4.2.3 Analysis by Applications
5 Germany Bioinformatics Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Germany Bioinformatics Market Segmentation
6.1 Germany Bioinformatics Market by Product and Services
6.1.1 Market Overview
6.1.2 Bioinformatics Platforms
6.1.2.1 Sequence Analysis Platforms
6.1.2.2 Sequence Alignment Platforms
6.1.2.3 Sequence Manipulation Platforms
6.1.2.4 Structural and Functional Analysis Platforms
6.1.2.5 Others
6.1.3 Knowledge Management Tools
6.1.3.1 Generalized Knowledge Management Tools
6.1.3.2 Specialized Knowledge Management Tools
6.1.4 Bioinformatics Services
6.1.4.1 Data Analysis
6.1.4.2 Sequencing Services
6.1.4.3 Database ad Management Services
6.1.4.4 Others
6.2 Germany Bioinformatics Market by Applications
6.2.1 Market Overview
6.2.2 Genomics and Drug Development
6.2.3 Proteomics
6.2.4 Evolutionary Studies
6.2.5 Agricultural Studies
6.2.6 Veterinary Science
6.2.7 Metabolomics
6.2.8 Transcriptomics
6.2.9 Others
6.3 Germany Bioinformatics Market by Sectors
6.3.1 Market Overview
6.3.2 Medical Biotechnology
6.3.3 Academics
6.3.4 Animal Biotechnology
6.3.5 Agricultural Biotechnology
6.3.6 Environmental Biotechnology
6.3.7 Forensic Biotechnology
6.3.8 Others
7 Patent Analysis
7.1 Analysis by Type of Patent
7.2 Analysis by Publication year
7.3 Analysis by Issuing Authority
7.4 Analysis by Patent Age
7.5 Analysis by CPC Analysis
7.6 Analysis by Patent Valuation
7.7 Analysis by Key Players
8 Grants Analysis
8.1 Analysis by year
8.2 Analysis by Amount Awarded
8.3 Analysis by Issuing Authority
8.4 Analysis by Grant Application
8.5 Analysis by Funding Institute
8.6 Analysis by NIH Departments
8.7 Analysis by Recipient Organization
9 Funding Analysis
9.1 Analysis by Funding Instances
9.2 Analysis by Type of Funding
9.3 Analysis by Funding Amount
9.4 Analysis by Leading Players
9.5 Analysis by Leading Investors
9.6 Analysis by Geography
10 Partnership and Collaborations Analysis
10.1 Analysis by Partnership Instances
10.2 Analysis by Type of Partnership
10.3 Analysis by Leading Players
10.4 Analysis by Geography
11 Regulatory Framework
11.1 Regulatory Overview
11.1.1 US FDA
11.1.2 EU EMA
11.1.3 INDIA CDSCO
11.1.4 JAPAN PMDA
11.1.5 Others
12 Suppliers Landscape
12.1 Affymetrix GmbH
12.1.1 Financial Analysis
12.1.2 Product Portfolio
12.1.3 Demographic Reach and Achievements
12.1.4 Mergers and Acquisitions
12.1.5 Certifications
12.2 Biovia
12.2.1 Financial Analysis
12.2.2 Product Portfolio
12.2.3 Demographic Reach and Achievements
12.2.4 Mergers and Acquisitions
12.2.5 Certifications
12.3 Biomax Informatics AG
12.3.1 Financial Analysis
12.3.2 Product Portfolio
12.3.3 Demographic Reach and Achievements
12.3.4 Mergers and Acquisitions
12.3.5 Certifications
12.4 Agilent Technologies
12.4.1 Financial Analysis
12.4.2 Product Portfolio
12.4.3 Demographic Reach and Achievements
12.4.4 Mergers and Acquisitions
12.4.5 Certifications
12.5 Life Technologies GmbH
12.5.1 Financial Analysis
12.5.2 Product Portfolio
12.5.3 Demographic Reach and Achievements
12.5.4 Mergers and Acquisitions
12.5.5 Certifications
12.6 Illumina GmbH
12.6.1 Financial Analysis
12.6.2 Product Portfolio
12.6.3 Demographic Reach and Achievements
12.6.4 Mergers and Acquisitions
12.6.5 Certifications
12.7 QIAGEN GmbH
12.7.1 Financial Analysis
12.7.2 Product Portfolio
12.7.3 Demographic Reach and Achievements
12.7.4 Mergers and Acquisitions
12.7.5 Certifications
12.8 PerkinElmer Holding GmbH
12.8.1 Financial Analysis
12.8.2 Product Portfolio
12.8.3 Demographic Reach and Achievements
12.8.4 Mergers and Acquisitions
12.8.5 Certifications
12.9 ID Business Solutions
12.9.1 Financial Analysis
12.9.2 Product Portfolio
12.9.3 Demographic Reach and Achievements
12.9.4 Mergers and Acquisitions
12.9.5 Certifications
12.10 Roche Diagnostics GmbH
12.10.1 Financial Analysis
12.10.2 Product Portfolio
12.10.3 Demographic Reach and Achievements
12.10.4 Mergers and Acquisitions
12.10.5 Certifications
13 Germany Bioinformatics Market - Distribution Model (Additional Insight)
13.1 Overview
13.2 Potential Distributors
13.3 Key Parameters for Distribution Partner Assessment
14 Key Opinion Leaders (KOL) Insights (Additional Insight)
15 Company Competitiveness Analysis (Additional Insight)
15.1 Very Small Companies
15.2 Small Companies
15.3 Mid-Sized Companies
15.4 Large Companies
15.5 Very Large Companies
16 Payment Methods (Additional Insight)
16.1 Government Funded
16.2 Private Insurance
16.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
The market size is anticipated to grow at a CAGR of 29% during the forecast period of 2024-2032.
German bioinformatics has witnessed a surge of new trends, shaping the future of the field globally. The emphasis on big data management, driven by the exponential growth of data from genomic sequencing and other technologies has contributed to the growth of German bioinformatics market.
The market is expected to witness exponential growth due to advancements in technologies, along with the rise in machine learning and artificial intelligence.
The different types of product and services offered in the market include bioinformatics platforms, knowledge management tools, and bioinformatics services. Bioinformatics platforms include sequence analysis, sequence manipulation, and structural and functional analysis platforms. Knowledge management tools include generalized and specialized knowledge management tools. Bioinformatics services include data analysis, sequencing services, database ad management services among others.
Bioinformatics find wide applications in genomics and drug development, proteomics, evolutionary studies, agricultural studies, veterinary science, metabolomics, and transcriptomics, among others.
The sectors available in the market are medical biotechnology, academics, animal biotechnology, agricultural biotechnology, environmental biotechnology, and forensic biotechnology, among others.
Key players in the market include Affymetrix GmbH, Biovia, Biomax Informatics AG, Agilent Technologies, Life Technologies GmbH, Illumina GmbH, QIAGEN GmbH, PerkinElmer Holding GmbH, ID Business Solutions, and Roche Diagnostics GmbH.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.